Dupuytren’s contracture can worsen over time if not treated, leading to fingers bending permanently toward the palm and potentially requiring surgery to regain function. The condition can ...
DUBLIN, Jan. 14, 2026 /PRNewswire/ -- Keenova Therapeutics plc announced today that it will present a live treatment procedure with XIAFLEX ® (collagenase clostridium histolyticum) for Dupuytren's ...
DUBLIN - Keenova Therapeutics plc (trading at $64.64, up 0.9% from previous close) announced Tuesday that findings from a national survey on patient perceptions of Dupuytren’s contracture (DC) will be ...
This marks the first live procedure at AAHS, as well as a first for Keenova. Treatment takes place over two days of annual meeting—injection on Wednesday and finger extension on Friday. Audience of ...
DUBLIN, Jan. 13, 2026 /PRNewswire/ — Keenova Therapeutics plc announced today that a new presentation related to Dupuytren’s contracture (DC) and XIAFLEX ® (collagenase clostridium histolyticum, or ...
Analysis to Be Presented at the American Association for Hand Surgery Meeting DUBLIN, Jan. 13, 2026 /PRNewswire/ -- Keenova Therapeutics plc announced today that a new presentation related to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results